A Canadian perception of the nursing practice, research, and theoretical implications associated with autologous cell transplantation.
Heart failure is a progressive disorder. An estimated 400,000 Canadians are diagnosed annually with heart failure, and a quarter experience severe heart failure that is unresponsive to medical therapy. Autologous cell transplantation has been proposed as a new approach for cardiac repair and holds enormous potential for the regeneration of injured myocardium cells. Currently, autologous cell transplantation is under investigation in Canada. Its use as a treatment alternative for heart failure patients has been established over the past 5 years across Europe and the United States. This article will present a Canadian perception of the nursing practice, research, and theoretical implications associated with this new and innovative therapy.
Fredericks
Suzanne
S
School of Nursing, Ryerson University, Toronto, Ontario, Canada. sfrederi@ryerson.ca
Da Silva
Monica
M
D002170:Canada; D017690:Cell Transplantation / Q000379:methods / Q000451:nursing; D006333:Heart Failure / Q000451:nursing* / Q000601:surgery*; D006801:Humans; D032448:Myoblasts, Skeletal / Q000637:transplantation*; D009736:Nursing Process; D015399:Nursing Research; D009742:Nursing Theory; D013527:Perioperative Nursing / Q000379:methods*; D014182:Transplantation, Autologous